Online Inquiry
Deferoxamine mesylate
SPC-00674
CAS No. 138-14-7
| Size | Price |
| 25 mg | Online Inquiry |
| Bulk Size | Online Inquiry |
Ferroptosis inhibitor ; Autophagy activator ; HIF activator ; Beta Amyloid inhibitor
| Description |
|---|
| Deferoxamine mesylate is the mesylate salt of Deferoxamine, which forms iron complexes and is used as a chelating agent. Deferoxamine is a ferroptosis inhibitor that stabilizes HIF-1α expression and improves HIF-1α transactivity in hypoxic and hyperglycemic states in vitro. Deferoxamine decreases beta-amyloid (Aβ) deposition and induces autophagy. |
| Product Details | |
|---|---|
| CAS No. | CAS No. 138-14-7 |
| Description | Deferoxamine mesylate is the mesylate salt of Deferoxamine, which forms iron complexes and is used as a chelating agent. Deferoxamine is a ferroptosis inhibitor that stabilizes HIF-1α expression and improves HIF-1α transactivity in hypoxic and hyperglycemic states in vitro. Deferoxamine decreases beta-amyloid (Aβ) deposition and induces autophagy. |
| Formula | C26H52N6O11S |
| Molecular Weight | 656.79 |
| Storage | 3 years -20°C powder 2 years -80°C in solvent |
| Synonyms | desferrioxamine B |
| SMILES | CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O |
| Usage | |
|---|---|
| Storage | 3 years -20°C powder 2 years -80°C in solvent |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.